American Diabetes Association - Professional Publications

American Diabetes Association - Professional Publications The monthly, peer-reviewed journal focuses primarily on the physiology and pathophysiology of diabetes and its complications.

ADA's publications - Diabetes, Diabetes Care, Diabetes, Obesity, and CardioMetabolic CARE, & Books - are premier scientific & medical resources for diabetes research, care, prevention, and treatment. With impact factors of 9.332 and 17.152, Diabetes and Diabetes Care are the premier journals devoted exclusively to original diabetes-related research:

Diabetes, ADA's flagship research publication,

is the highest-ranked journal devoted to basic diabetes research. Diabetes Care, also a monthly peer-reviewed research publication, is the highest ranked journal devoted exclusively to diabetes treatment, care, and prevention. ADA treatment guidelines, position statements, and clinical practice recommendations are published in Diabetes Care. Clinical Diabetes and Diabetes Spectrum are ADA’s two cutting-edge “translational” journals:

Clinical Diabetes is a quarterly journal for primary care physicians, general practitioner, and other health care professionals. Each issue contains one or more feature articles that focus on the latest trends and innovations in diabetes care and treatment, as well as mini-reviews of landmark studies, practical treatment pointers, and best practices related to diabetes care. Clinical Diabetes focuses on translating recent diabetes-related research into clinical applications. Diabetes Spectrum is a quarterly journal for diabetes educators, nutritionists, nurse practitioners, and other health care providers. The journal’s “From Research to Practice” section provides in-depth explorations of selected diabetes care topics, with a primary focus on translating current research findings into educational and treatment strategies. ADA’s Standards of Medical Care in Diabetes are the most essential and up-to-date resource for clinicians, dietitians, and educators on the treatment of diabetes. Published each year with the January issue of Diabetes Care, the CPRs include ADA's standards for diagnosing and treating diabetes, nutrition recommendations and principles, and position statements on managing diabetes and its complications in various settings.

🚨 For May, we've got a brand new ep of , the that covers the most important articles in the field of .🎧Listen at: ht...
05/01/2026

🚨 For May, we've got a brand new ep of , the that covers the most important articles in the field of .

🎧Listen at: https://bit.ly/DOC_Update

Topics include:
✨GLP-1s & Ischemic Optic Neuropathy
✨Dulaglutide vs Semaglutide & CVD
✨and more!

FEATURED ARTICLES:
✨ Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial Emulations doi.org/10.2337/dc25-3063
✨ Association Between GLP-1 Receptor Agonists and Ischemic Optic Neuropathy: A Meta-analysis doi.org/10.2337/dc25-1238

Hosted by Drs. Neil Skolnik & John Russell

American Diabetes Association – DiabetesPro American Diabetes Association

⭐ 📖 Paper of the Month: MayTomosyn-2 Regulates Postnatal β-Cell Expansion and Insulin Secretion to Maintain Glucose Home...
04/21/2026

⭐ 📖 Paper of the Month: May
Tomosyn-2 Regulates Postnatal β-Cell Expansion and Insulin Secretion to Maintain Glucose Homeostasis ➡️ https://doi.org/10.2337/db25-0644

Articles chosen 🗓️ monthly & 🆓 online

👀 The May 2026 Diabetes Care is here, with the latest research on management.🔗 http://diabetesjournals.org/care/issue/...
04/20/2026

👀 The May 2026 Diabetes Care is here, with the latest research on management.

🔗 http://diabetesjournals.org/care/issue/49/5

Featuring:
✨GLP-1s & Diabetic Foot Ulcers
✨Glycemic Biomarkers & Patients Treated w Maintenance Dialysis
✨& more!

FEATURING:
✨ Effect of Semaglutide on Insulin Dose Reduction in Adults With Type 1 Diabetes and Obesity Using Automated Insulin Delivery Systems: ADJUST-T1D Post Hoc Analysis doi.org/10.2337/dc25-2249
✨ GLP-1 Receptor Agonists Are Associated With Reduced Mortality Following Diabetic Foot Ulcers: A Nationwide Observational Study doi.org/10.2337/dc25-2120
✨ Effect of High-Dose Oral Insulin in Children With Stage 1 Type 1 Diabetes: The Fr1da Insulin Intervention Randomized Controlled Trial doi.org/10.2337/dc25-2818
✨ Accuracy, Variability, and Bias of Glycemic Biomarkers in Patients Treated With Maintenance Dialysis doi.org/10.2337/dc25-2952

📷 On the cover: "The Takeoff," oil and graphite on canvas, 2025, Sarita Fonseca, MBA, CFAE. This artwork is an adaptation of a photograph taken at the New Orleans Congo Square Rhythms Festival by Eric Simon, MD, Tulane University School of Medicine, New Orleans, LA

American Diabetes Association – DiabetesPro American Diabetes Association

🚨The May 2026 issue of Diabetes has arrived!🔗 http://diabetesjournals.org/diabetes/issue/75/5Explore the latest research...
04/20/2026

🚨The May 2026 issue of Diabetes has arrived!

🔗 http://diabetesjournals.org/diabetes/issue/75/5

Explore the latest research on , including:
✨Quantitative β-cell mass imaging
✨Tomosyn-2 & Insulin Secretion
✨& more!

FEATURING:
✨ Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes doi.org/10.2337/db25-1127
✨ Tomosyn-2 Regulates Postnatal β-Cell Expansion and Insulin Secretion to Maintain Glucose Homeostasis doi.org/10.2337/db25-0644
✨ ANGPTL4 Induces Aberrant Lymphatic-Like Remodeling in Proliferative Diabetic Retinopathy doi.org/10.2337/db25-0445
✨Associations of Combined Genetic and Lifestyle Risks with Incident Type 2 Diabetes in the UK Biobank doi.org/10.2337/db25-0672

📸 On the cover: Neonatal islet showing proliferating β-cells. Shown is the mouse pancreatic section, highlighting proliferating cells (red) and insulin-positive β-cells in green. Nuclei are blue. Photography is courtesy of Katherine C. Perez and Sushant Bhatnagar, Comprehensive Diabetes Center and Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Alabama, Birmingham, AL. Their article, “Tomosyn-2 Regulates Postnatal β-Cell Expansion and Insulin Secretion to Maintain Glucose Homeostasis,” appears in this issue of "Diabetes."

American Diabetes Association – DiabetesPro American Diabetes Association

Stay connected with ADA Professional Publications! Follow us for the latest updates:🦋 Bluesky: ADA Publications | bsky.a...
04/18/2026

Stay connected with ADA Professional Publications! Follow us for the latest updates:

🦋 Bluesky: ADA Publications | bsky.app/profile/adapubs.bsky.social
📢 X (Twitter): x.com/ada_pubs | x.com/DiabetescareADA | x.com/Diabetes_ADA
📘 Facebook: ADA Publications | facebook.com/adaPublications
🎙 YouTube Podcasts: American Diabetes Association | youtube.com//podcasts

Stay informed—follow us today!

🥳 The American Diabetes Association would like to extend our sincere gratitude and appreciation and give a huge shout-ou...
04/16/2026

🥳 The American Diabetes Association would like to extend our sincere gratitude and appreciation and give a huge shout-out to our top expert reviewers. ADA's journal, Diabetes, would not be possible without you and your dedication! Our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. Thank you for advancing the research and accelerating the cause. It all Matters!
https://bit.ly/4mjl6bm

04/15/2026

🚨 NEW special Diabetes Core Update

In this special episode of Diabetes Core Update, explores new emerging technologies for people with diabetes.

👂 Listen now at: https://diabetesjournals.org/journals/pages/podcasts_whats_next

American Diabetes Association – DiabetesPro American Diabetes Association

🥳 The American Diabetes Association would like to extend our sincere gratitude and appreciation and give a huge shout-ou...
04/15/2026

🥳 The American Diabetes Association would like to extend our sincere gratitude and appreciation and give a huge shout-out to our top expert reviewers. Diabetes Care would not be possible without you and your dedication! Our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. Thank you for advancing the research and accelerating the cause. It all Matters!

https://bit.ly/4dG6pwP

04/14/2026

Global Reach🌍 . Practical Insight. Our journal portfolio delivers highly cited, mission-driven research that advances diabetes and obesity science and care worldwide. Now expanded with Diabetes, Obesity, and Cardiometabolic CARE® Explore: https://bit.ly/4lbA0QB

04/13/2026

📚 NOW AVAILABLE: The 2025-26 Guide to Medications for the Treatment of Diabetes Mellitus
We're excited to announce that the most comprehensive diabetes medication reference for healthcare professionals is now available!
This newly revised guide covers everything clinicians need to know about diabetes pharmacology, including:
✓ Complete coverage of all diabetes drug classes
✓ Latest American Diabetes Association Standards of Care
✓ Medication management for key comorbidities (neuropathy, CKD, retinopathy, hypoglycemia, obesity, and depression)
Compiled by leading pharmacology experts specializing in diabetes care, this essential resource is designed for physicians, clinicians, and educators committed to providing optimal diabetes treatment.

📖 Read individual chapters online: doi.org/10.2337/9781580408462
🛒 Purchase your printed copy: shopdiabetes.org/collections/professional-books/products/2025-26-guide-to-medications-for-the-treatment-of-diabetes-mellitus

Just released!🚨 The 2026 Abridged Standards of Care for Primary Care professionals is here. Developed by the ADA’s Prima...
04/09/2026

Just released!🚨 The 2026 Abridged Standards of Care for Primary Care professionals is here. Developed by the ADA’s Primary Care Advisory Group, this new resource contains the evidence-based clinical practice recommendations most pertinent to primary care—presented in a user-friendly format. Its recommendations are substantively the same as in the complete ADA Standards of Care, but delivered in succinct bullet points and helpful graphics.

Section now hosted in ADA's new journal, Diabetes, Obesity, and CardioMetabolic CARE.

Read free ➡️ https://bit.ly/48gGFU5

Targeting insulin resistance, rather than hyperglycemia, before stroke in is crucial to improving stroke outcomes. Re...
04/09/2026

Targeting insulin resistance, rather than hyperglycemia, before stroke in is crucial to improving stroke outcomes.

Read here ➡️ doi.org/10.2337/db25-0532

American Diabetes Association
American Diabetes Association – DiabetesPro

Address

2451 Crystal Drive, Suite 900
Arlington, VA
22202

Telephone

+17035491500

Website

https://diabetesjournals.org/journals/pages/podcasts, https://diabetesjournals.org/journa

Alerts

Be the first to know and let us send you an email when American Diabetes Association - Professional Publications posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to American Diabetes Association - Professional Publications:

Shortcuts

Share

Category